logo
‘My Blood, for My Country' campaign proves life-saver

‘My Blood, for My Country' campaign proves life-saver

Gulf Today17-06-2025
Marking World Blood Donor Day, observed annually on 14 June, Dubai Health held a ceremony to honour the collective efforts of the community and recognise key contributors to the 'My Blood, for My Country' campaign, including government entities, private institutions, and individual donors, who have played a vital role in the campaign's success since its launch in 2012.
A total of 43 strategic partners were recognised during the event. This included 11 government entities; 10 private institutions, including charities and foundations; and 22 individual donors.
The campaign is a collaboration between Dubai Health, Al Ameen Service, Dubai Health Authority (DHA), and the Emarat Al Youm newspaper. Over the past 13 years, it has helped ensure a steady supply of blood for patients in both public and private healthcare facilities, including Dubai Health's Thalassemia Center, while promoting a culture of voluntary blood donation across the community as a humanitarian and social responsibility.
Since its inception, the campaign has encouraged the participation of over 300,000 donors, helping collect more than 500,000 units of blood and playing a crucial role in saving lives.
The 'My Blood, for My Country' campaign aims to embed blood donation as a vital humanitarian and national responsibility, while expanding the donor base, especially among those with rare blood types and first-time donors.
A key focus of the campaign is to engage youth aged 18 to 30, promoting blood donation as part of a healthy, socially responsible lifestyle. Public and private organisations are also encouraged to conduct and support donation drives.
Speaking at the event, Dr. Muna Tahlak, Chief Medical Officer at Dubai Health, expressed her gratitude to the campaign's strategic partners, whose sustained support has directly contributed to life-saving efforts.
She noted that over the campaign's 13-year journey, more than 300,000 donors from 150 different nationalities contributed to collecting over 500,000 units of blood. In 2024 alone, the initiative saw a notable increase in first-time donors, who accounted for 54% of the total, while youth made up 41% of the donor base.
Dr Tahlak highlighted the campaign's positive outcomes and longevity, which reflect the strong community support it has received since its launch. She thanked everyone who has donated blood to help save lives and called on all members of the community to continue supporting the campaign and championing a culture of voluntary blood donation.
Omar Al Falasi, General Supervisor of Al Ameen Service, affirmed that the 'My Blood, for My Country' campaign continues to promote a spirit of solidarity among members of the community, as it carries messages of giving and humanitarian work, besides inspiring a spirit of initiative within society.
Al Falasi added that over the course of a decade, the campaign has reflected positive outcomes for the community, both for donors and those in need, contributing to disease prevention and raising overall health standards in the country. He also noted that the Al Ameen Service continues to enhance its positive role in consistently contributing to the safety and health of community members.
Mona Bajman, CEO of the Shared Support Services Sector at the Dubai Health Authority (DHA), stated that the 'My Blood, for My Country' campaign has become a pioneering model of sustainable community engagement. The initiative has delivered tangible results in supporting the national blood donation system and in promoting a culture of compassion and giving across the country.
She commended the vital role played by all supporting stakeholders-including government and private sector institutions, voluntary initiatives, and individuals-affirming that this constructive collaboration has been instrumental in the campaign's success and in achieving its humanitarian and health-related objectives.
She further highlighted that the lasting impact of the campaign over 13 years, along with the steady increase in donor numbers and the expansion of community participation, reflects both institutional and societal commitment to supporting national humanitarian initiatives. Its success also underscores the value of strong partnerships in ensuring long-term positive outcomes.
Ibrahim Shukrallah, Editor-in-Chief of Emarat Al Youm Newspaper, stressed that the 'My Blood, for My Nation' campaign has become one of the UAE's most prominent models for instilling a culture of blood donation and fostering volunteer-driven humanitarian work. He pointed out that the campaign's achievements over more than a decade reflect the solidarity between national institutions and members of society in saving lives and supporting patients in critical need of blood.
He stated that Emarat Al Youm is proud to have been a strategic partner in this pioneering national initiative since its inception, and considers supporting the campaign as its professional and humanitarian duty. He explained that Emarat Al Youm has, over the past several years, employed all its media capabilities, from digital platforms to print, to share the campaign's message with the widest possible audience, and encourage active community participation in blood donations.
He added that honouring donors and partners is a gesture of recognition and gratitude for everyone who contributed to the campaign's success. It also serves as an invitation to the community to continue promoting a culture of blood donation. He emphasised that the national press continues to be a vital partner in supporting initiatives that make a real difference in people's lives.
WAM
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Dubai Police Arrest Three Women for Illegal Cosmetic Procedures
Dubai Police Arrest Three Women for Illegal Cosmetic Procedures

Filipino Times

time7 days ago

  • Filipino Times

Dubai Police Arrest Three Women for Illegal Cosmetic Procedures

Dubai Police have detained three women accused of illegally practicing medicine and performing cosmetic treatments without a licence inside a residential apartment. Officials said these activities violated UAE laws and posed serious risks to public health. The Anti-Economic Crime Department, working with the Dubai Health Authority (DHA), acted on a tip-off about suspicious operations in the apartment. After verifying the information, officers raided the premises, confiscating medical tools and unlicensed medications. The suspects have been referred to the public prosecution for further legal proceedings. Authorities warned that undergoing medical or cosmetic procedures in unlicensed locations can endanger clients' safety. Residents are advised to seek services only from licensed clinics, verify practitioner credentials, and avoid risky offers. The public is encouraged to report illegal medical practices via the 'Police Eye' platform or by calling 901. Dubai Police reaffirmed their commitment to combatting unlicensed medical activities and ensuring community safety.

Dubai Health Scientists Publish First Arab Pangenome Reference, Advancing Precision Medicine in the Region
Dubai Health Scientists Publish First Arab Pangenome Reference, Advancing Precision Medicine in the Region

Hi Dubai

time25-07-2025

  • Hi Dubai

Dubai Health Scientists Publish First Arab Pangenome Reference, Advancing Precision Medicine in the Region

Scientists at the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), the academic and research arm of Dubai Health, have published the first-ever Arab Pangenome Reference. The landmark study, featured in the peer-reviewed journal Nature Communications , sets a new benchmark for precision medicine and personalised healthcare in the region. The breakthrough aligns with the UAE's National Genome Strategy, a 10-year plan launched by the Emirates Genome Council in 2023 to enhance preventive and precision-based care using genomic science. The Arab Pangenome Reference is a foundational contribution to this vision. Built using high-quality DNA sequencing data from 53 individuals of diverse Arab descent residing in the UAE, the reference fills a critical gap in global genetic databases, which have long underrepresented Arab populations. The research uncovered over 110 million base pairs of novel DNA sequences and identified nearly 9 million small genetic variants, along with over 235,000 large structural differences unique to Arab genomes. These findings are significant not just for the region, but for the global scientific community, said Prof. Alawi Alsheikh-Ali, Director General of the Dubai Health Authority and co-author of the study. We are enabling more precise and equitable healthcare by building a genome reference that reflects our population. One of the study's key discoveries includes the identification of a duplicated gene, TAF11L5, which was found to be highly enriched in Arab individuals but absent in current global references. This gene may influence the activity of other genes, with potential implications for disease risk and treatment response. The research was conducted entirely in-house at MBRU's Center for Applied and Translational Genomics (CATG). This integration allowed us to control the full research pipeline—from sequencing to bioinformatics—ensuring top-tier quality, said Dr. Hanan Al Suwaidi, Acting Provost at MBRU and co-author of the study. As part of the initiative, the team also developed a new open-source bioinformatics tool called PanScan, which facilitates the detection of gene duplications and complex DNA structures. The tool is now publicly accessible on GitHub, enabling scientists worldwide to benefit from the work. Dr. Mohammed Uddin, Director of CATG and senior author of the study, noted: This pangenome reference is a major step in understanding Arab genetic diversity. It will be a critical asset for both research and clinical diagnostics. The study not only enhances the scientific understanding of Arab genomics but also reinforces Dubai Health's long-term commitment to world-class research and innovation in healthcare. MBRU's research strategy continues to contribute meaningful data to international scientific efforts, while ensuring local populations are represented in global health advancements. The full study can be accessed at Nature Communications. News Source: Dubai Media Office

Dubai Health scientists publish first Arab Pangenome Reference, marking a milestone for precision medicine
Dubai Health scientists publish first Arab Pangenome Reference, marking a milestone for precision medicine

Emirates 24/7

time24-07-2025

  • Emirates 24/7

Dubai Health scientists publish first Arab Pangenome Reference, marking a milestone for precision medicine

Scientists at the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), the learning and discovery arm of Dubai Health, have published the first Arab Pangenome Reference, marking a major milestone in both regional and global genomic research. The study, released in Nature Communications, a leading scientific journal, provides a crucial foundation for advancing precision medicine and personalised healthcare for Arab populations, while also supporting the UAE's National Genome Strategy, a 10-year initiative launched in 2023 by the Emirates Genome Council to advance personalised, preventive, and precision healthcare through cutting-edge genomic science. The reference was built using high-quality DNA sequencing from 53 people of diverse Arab backgrounds in the UAE. The work, conducted in MBRU's state-of-the-art Center for Applied and Translational Genomics (CATG), uncovered over 110 million base pairs of novel DNA sequences and identified nearly nine million small differences and more than 235,000 larger structural differences specific to Arab populations that have not been reported before. These findings are significant, as global DNA references have historically underrepresented Arab populations — a gap this research helps to close. The Arab Pangenome Reference supports national and regional precision medicine initiatives by enabling the development of population-specific biomarkers, risk models, and therapeutic targets. One notable discovery was the duplicated gene TAF11L5, found highly enriched in Arab individuals studied but absent from global references. This gene may play a role in regulating other genes and could have implications for understanding disease risk and individual variation in treatment response. Professor Alawi Alsheikh-Ali, Director General, Dubai Health Authority, and co-author of the study, said: 'This achievement strengthens the UAE's position in genomic science. By building a reference that reflects the genetic diversity of Arab populations, we are enabling more precise and equitable healthcare. It's a foundational step towards realising the goals of our National Genome Strategy and ensuring that future medical innovations are shaped by data from our own communities.' Dr. Hanan Al Suwaidi, Acting Provost of MBRU, and co-author of the study said: 'The capabilities of the CATG lab were central to the success of this project. From genetic sequencing to advanced bioinformatics, every stage of the research was completed in-house. This level of integration gave us full control over quality and timelines, reflecting Dubai Health's commitment to building world-class infrastructure and fostering national scientific leaders." While genomic research has advanced rapidly over the past two decades, much of the foundational data has come from a narrow subset of global populations. This has created blind spots in how genetic risk is understood and addressed across different communities. The Arab Pangenome Reference contributes to a growing international effort to correct this imbalance by introducing high-quality data from a historically underrepresented population. Dr. Mohammed Uddin, Director of CATG and Associate Professor of Genetics at MBRU, and senior author of the study, said: 'This pangenome reference marks a major advancement in our understanding of Arab genomic diversity. It serves as a critical resource for both research discovery and clinical genome diagnostics, with lasting impact for future generations across the region.' The project also developed 'PanScan', a bioinformatics tool to support more complex analysis of human pangenomes. Although not the central focus of the study, PanScan enables researchers to detect gene duplications, novel DNA changes, and complex DNA structures. Now publicly available on GitHub, a common resource used by scientists worldwide, the tool was created to support the Arab Pangenome Reference and similar efforts globally. Dr. Nasna Nassir, lead author of the study and Assistant Professor at MBRU, said: 'To support the Arab Pangenome Reference study, we developed PanScan, a tool designed to identify novel variants, gene duplications, and complex haplotype patterns specific to Arab populations. PanScan was key to uncovering unique genomic insights in our study and is now publicly available to support similar research globally.' The research reflects Dubai Health's commitment to advancing learning and discovery through MBRU. The university's research strategy is focused on contributing to global scientific progress. By investing in foundational genomic research, Dubai Health is helping to ensure that Arab populations are represented in the future of precision healthcare. The full study is available at:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store